This is a Validated Antibody Database (VAD) review about mouse Gm8909, based on 52 published articles (read how Labome selects the articles), using Gm8909 antibody in all methods. It is aimed to help Labome visitors find the most suited Gm8909 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
Gm8909 synonym: EG667977; H2-Tw5l; H2-gs17

BioLegend
mouse monoclonal (25-D1.16)
  • flow cytometry; mouse; loading ...; fig 1c
BioLegend Gm8909 antibody (Biolegend, 141604) was used in flow cytometry on mouse samples (fig 1c). Cell (2019) ncbi
mouse monoclonal (AF6-88.5)
  • flow cytometry; mouse; fig 4a
BioLegend Gm8909 antibody (BioLegend, AF6-88.5) was used in flow cytometry on mouse samples (fig 4a). J Clin Invest (2019) ncbi
mouse monoclonal (KH95)
  • flow cytometry; mouse; loading ...; fig 1b
BioLegend Gm8909 antibody (BioLegend, KH95) was used in flow cytometry on mouse samples (fig 1b). J Exp Med (2019) ncbi
mouse monoclonal (AF6-88.5)
  • flow cytometry; mouse; loading ...; fig 1b
BioLegend Gm8909 antibody (BioLegend, AF6-88.5) was used in flow cytometry on mouse samples (fig 1b). J Exp Med (2019) ncbi
mouse monoclonal (AF6-88.5)
  • flow cytometry; mouse; loading ...; fig 2a
BioLegend Gm8909 antibody (BioLegend, AF6-88.5) was used in flow cytometry on mouse samples (fig 2a). PLoS ONE (2018) ncbi
mouse monoclonal (KH95)
  • flow cytometry; mouse; loading ...; fig 4a
BioLegend Gm8909 antibody (BioLegend, KH95) was used in flow cytometry on mouse samples (fig 4a). JCI Insight (2018) ncbi
mouse monoclonal (AF6-88.5)
  • flow cytometry; mouse; loading ...; fig 4a
BioLegend Gm8909 antibody (BioLegend, AF6-88.5) was used in flow cytometry on mouse samples (fig 4a). JCI Insight (2018) ncbi
mouse monoclonal (AF6-88.5)
BioLegend Gm8909 antibody (Biolegend, 116517) was used . elife (2018) ncbi
mouse monoclonal (25-D1.16)
  • flow cytometry; mouse; 1:200; loading ...; fig 1c
BioLegend Gm8909 antibody (Biolegend, 141605) was used in flow cytometry on mouse samples at 1:200 (fig 1c). elife (2018) ncbi
mouse monoclonal (AF6-88.5)
  • flow cytometry; mouse; loading ...; fig s8a
BioLegend Gm8909 antibody (Biolegend, AF6-88.5) was used in flow cytometry on mouse samples (fig s8a). Science (2018) ncbi
mouse monoclonal (KH95)
  • flow cytometry; mouse; loading ...; fig s1b
BioLegend Gm8909 antibody (Biolegend, KH95) was used in flow cytometry on mouse samples (fig s1b). Cancer Immunol Immunother (2019) ncbi
mouse monoclonal (KH95)
  • flow cytometry; mouse; loading ...; fig s1b
BioLegend Gm8909 antibody (BioLegend, KH95) was used in flow cytometry on mouse samples (fig s1b). J Clin Invest (2019) ncbi
mouse monoclonal (AF6-88.5)
  • flow cytometry; mouse; loading ...; fig 2d
BioLegend Gm8909 antibody (BioLegend, AF6-88.5) was used in flow cytometry on mouse samples (fig 2d). PLoS ONE (2018) ncbi
mouse monoclonal (34-1-2S)
  • flow cytometry; mouse; 1:200; loading ...; fig s1a
BioLegend Gm8909 antibody (Biolegend, 34-1-2 S) was used in flow cytometry on mouse samples at 1:200 (fig s1a). Oncoimmunology (2018) ncbi
mouse monoclonal (AF6-88.5)
  • flow cytometry; mouse; loading ...; fig s1a
BioLegend Gm8909 antibody (Biolegend, 116507) was used in flow cytometry on mouse samples (fig s1a). Cell (2018) ncbi
mouse monoclonal (KH95)
  • flow cytometry; mouse; fig 6a
In order to show that parasite-specific CD8 positive T cell-induced fatal vascular breakdown and subsequent neuronal death in an animal model of cerebral malaria, BioLegend Gm8909 antibody (BioLegend, KH95) was used in flow cytometry on mouse samples (fig 6a). PLoS Pathog (2016) ncbi
mouse monoclonal (AF6-88.5)
  • flow cytometry; mouse; fig 6a
In order to show that parasite-specific CD8 positive T cell-induced fatal vascular breakdown and subsequent neuronal death in an animal model of cerebral malaria, BioLegend Gm8909 antibody (BioLegend, AF6-88.5) was used in flow cytometry on mouse samples (fig 6a). PLoS Pathog (2016) ncbi
mouse monoclonal (AF6-88.5)
  • flow cytometry; mouse; fig 6b
In order to assess the effects of a genetically encoded chimeric MyD88/CD40 adjuvant, BioLegend Gm8909 antibody (BioLegend, 116508) was used in flow cytometry on mouse samples (fig 6b). PLoS ONE (2016) ncbi
mouse monoclonal (KH114)
In order to assess the effects of a genetically encoded chimeric MyD88/CD40 adjuvant, BioLegend Gm8909 antibody (BioLegend, 115106) was used . PLoS ONE (2016) ncbi
mouse monoclonal (AF6-88.5)
  • flow cytometry; mouse; fig 2
BioLegend Gm8909 antibody (Biolegend, AF6-88.5) was used in flow cytometry on mouse samples (fig 2). Sci Rep (2016) ncbi
mouse monoclonal (25-D1.16)
  • flow cytometry; mouse; loading ...; fig 3f
BioLegend Gm8909 antibody (BioLegend, 25-D1.16) was used in flow cytometry on mouse samples (fig 3f). Oncotarget (2016) ncbi
mouse monoclonal (25-D1.16)
  • western blot; mouse
BioLegend Gm8909 antibody (Biolegend, 141605) was used in western blot on mouse samples . J Vis Exp (2015) ncbi
mouse monoclonal (KH95)
  • flow cytometry; mouse
BioLegend Gm8909 antibody (BioLegend, KH95) was used in flow cytometry on mouse samples . Blood (2014) ncbi
mouse monoclonal (AF6-88.5)
  • flow cytometry; mouse
In order to study the involvement of signal peptide peptidase in MHC class I presentation, BioLegend Gm8909 antibody (Biolegend, AF6-88.5) was used in flow cytometry on mouse samples . J Immunol (2013) ncbi
Invitrogen
mouse monoclonal (28-14-8)
  • flow cytometry; mouse; loading ...; fig 4a
Invitrogen Gm8909 antibody (eBioscience, 28-14-8) was used in flow cytometry on mouse samples (fig 4a). J Exp Med (2018) ncbi
mouse monoclonal (W6/32)
  • flow cytometry; human; loading ...; fig 1a
Invitrogen Gm8909 antibody (eBioscience, W6/32) was used in flow cytometry on human samples (fig 1a). J Immunol (2018) ncbi
mouse monoclonal (W6/32)
  • blocking or activating experiments; human; loading ...; fig s2b
Invitrogen Gm8909 antibody (eBiosciences, w6/32) was used in blocking or activating experiments on human samples (fig s2b). Nat Med (2018) ncbi
mouse monoclonal (AF6-88.5.5.3)
  • flow cytometry; mouse; loading ...; fig e5c
Invitrogen Gm8909 antibody (eBiosciences, AF6-88.5.5.3) was used in flow cytometry on mouse samples (fig e5c). Nature (2018) ncbi
mouse monoclonal (AF6-88.5.5.3)
  • flow cytometry; mouse; loading ...; fig s2f
Invitrogen Gm8909 antibody (eBioscience, 17-5958) was used in flow cytometry on mouse samples (fig s2f). Nat Med (2018) ncbi
mouse monoclonal (AF6-88.5.5.3)
  • flow cytometry; mouse; loading ...; fig 1f
In order to investigate the involvement of Sec22b in antigen cross-presentation and antitumor immunity, Invitrogen Gm8909 antibody (eBiosciences, 11-5958-80) was used in flow cytometry on mouse samples (fig 1f). J Exp Med (2017) ncbi
mouse monoclonal (34-1-2S)
  • flow cytometry; mouse; loading ...; fig 4c
In order to study intestinal immune responses during acute graft-versus-host disease, Invitrogen Gm8909 antibody (eBiosciences, 34-1-2S) was used in flow cytometry on mouse samples (fig 4c). J Clin Invest (2017) ncbi
mouse monoclonal (SF1-1.1.1)
  • flow cytometry; mouse; 1:50; loading ...; fig 9a
In order to study the immune responses in mice infected with GFP-expressing Rickettsia typhi, Invitrogen Gm8909 antibody (eBioscience, SF1-1.1.1) was used in flow cytometry on mouse samples at 1:50 (fig 9a). Infect Immun (2017) ncbi
mouse monoclonal (SF1-1.1.1)
  • flow cytometry; mouse; loading ...; fig s5
In order to study the role of moesin during the generation of TGF-beta-induced T regulatory cells, Invitrogen Gm8909 antibody (eBioscience, SF1-1.1) was used in flow cytometry on mouse samples (fig s5). J Clin Invest (2017) ncbi
mouse monoclonal (SF1-1.1.1)
  • flow cytometry; mouse; fig 1
In order to study the contribution of extracellular vesicle to maternal microchimerism, Invitrogen Gm8909 antibody (eBioscience, SF1-1.1.1) was used in flow cytometry on mouse samples (fig 1). Proc Natl Acad Sci U S A (2017) ncbi
mouse monoclonal (W6/32)
  • flow cytometry; human; loading ...; fig s9a
Invitrogen Gm8909 antibody (eBiosciences, W6/32) was used in flow cytometry on human samples (fig s9a). PLoS Pathog (2016) ncbi
mouse monoclonal (AF6-88.5)
  • flow cytometry; mouse; fig 1c
In order to study the role of MCH I in natural killer cell tolerance and hyporesponsiveness, Invitrogen Gm8909 antibody (eBioscience, AF6-88.5) was used in flow cytometry on mouse samples (fig 1c). J Immunol (2016) ncbi
mouse monoclonal (SF1-1.1.1)
  • blocking or activating experiments; mouse; loading ...
In order to establish and characterize a mouse model of narcolepsy, Invitrogen Gm8909 antibody (eBioscience, SF1-1.1.1) was used in blocking or activating experiments on mouse samples . Proc Natl Acad Sci U S A (2016) ncbi
mouse monoclonal (SF1-1.1.1)
  • flow cytometry; mouse; 1:200; loading ...; fig 9b
In order to investigate the contribution of neutrophils and macrophages during Rickettsia typhi infection, Invitrogen Gm8909 antibody (eBioscience, SF1-1.1.1) was used in flow cytometry on mouse samples at 1:200 (fig 9b). PLoS Negl Trop Dis (2016) ncbi
mouse monoclonal (AF6-88.5.5.3)
  • flow cytometry; mouse; 1:100; fig s5
Invitrogen Gm8909 antibody (eBioscience, 48-5958-80) was used in flow cytometry on mouse samples at 1:100 (fig s5). Nat Commun (2016) ncbi
mouse monoclonal (W6/32)
  • flow cytometry; human; 1:50; fig s2j
In order to develop and characterize a humanized ossicle xenotransplantation approach, Invitrogen Gm8909 antibody (ebioscience, W6/32) was used in flow cytometry on human samples at 1:50 (fig s2j). Nat Med (2016) ncbi
mouse monoclonal (28-14-8)
  • flow cytometry; mouse; 1:250; fig 3
In order to assess the role of NLRC5 to NK-T-cell crosstalk, Invitrogen Gm8909 antibody (eBioscience, 28-14-8) was used in flow cytometry on mouse samples at 1:250 (fig 3). Nat Commun (2016) ncbi
mouse monoclonal (34-1-2S)
  • flow cytometry; mouse; 1:150; fig s1
In order to assess the role of NLRC5 to NK-T-cell crosstalk, Invitrogen Gm8909 antibody (eBioscience, 34-1-2S) was used in flow cytometry on mouse samples at 1:150 (fig s1). Nat Commun (2016) ncbi
mouse monoclonal (W6/32)
  • immunohistochemistry - paraffin section; human; 1:5000; fig 4
In order to determine if there is an association between inclusion body myositis and hepatitis C virus infection, Invitrogen Gm8909 antibody (Thermo Fisher Scientific, W6/32) was used in immunohistochemistry - paraffin section on human samples at 1:5000 (fig 4). Neurology (2016) ncbi
mouse monoclonal (28-14-8)
  • flow cytometry; mouse; fig 3
Invitrogen Gm8909 antibody (eBioscience, 28-14-8) was used in flow cytometry on mouse samples (fig 3). Carbohydr Polym (2015) ncbi
mouse monoclonal (28-14-8)
  • flow cytometry; mouse
Invitrogen Gm8909 antibody (eBioscience, 28-14-8) was used in flow cytometry on mouse samples . Eur J Immunol (2014) ncbi
mouse monoclonal (28-14-8)
  • flow cytometry; mouse; fig 4
In order to investigate the use of mannosylated synthetic long peptides for vaccination, Invitrogen Gm8909 antibody (eBiosciences, 28-14-8) was used in flow cytometry on mouse samples (fig 4). PLoS ONE (2014) ncbi
mouse monoclonal (SF1-1.1.1)
  • flow cytometry; mouse
Invitrogen Gm8909 antibody (eBioscience, 17-5957-82) was used in flow cytometry on mouse samples . Eur J Immunol (2014) ncbi
mouse monoclonal (SF1-1.1.1)
  • blocking or activating experiments; mouse
Invitrogen Gm8909 antibody (eBioScience, SF1-1.1.1) was used in blocking or activating experiments on mouse samples . PLoS ONE (2014) ncbi
mouse monoclonal (AF6-88.5.5.3)
  • flow cytometry; human
  • immunocytochemistry; human; fig 3
Invitrogen Gm8909 antibody (eBioscience, 11-5958-82) was used in flow cytometry on human samples and in immunocytochemistry on human samples (fig 3). J Immunol (2014) ncbi
mouse monoclonal (AF6-88.5.5.3)
  • flow cytometry; mouse
Invitrogen Gm8909 antibody (eBioscience, AF6-88.5.5.3) was used in flow cytometry on mouse samples . J Immunol (2014) ncbi
mouse monoclonal (SF1-1.1.1)
  • flow cytometry; mouse
Invitrogen Gm8909 antibody (eBioscience, SF1-1.1.1) was used in flow cytometry on mouse samples . J Immunol (2014) ncbi
mouse monoclonal (AF6-88.5.5.3)
  • flow cytometry; mouse
Invitrogen Gm8909 antibody (eBioscience, AF6-88.5.5.3) was used in flow cytometry on mouse samples . Br J Cancer (2014) ncbi
mouse monoclonal (W6/32)
  • western blot; human
In order to report that the human herpesvirus-7 U21 gene product interferes with natural killer cell recognition, Invitrogen Gm8909 antibody (Zymed Laboratories, W6/32) was used in western blot on human samples . PLoS Pathog (2011) ncbi
mouse monoclonal (34-1-2S)
  • flow cytometry; mouse
In order to investigate crosstalk between that osteoclasts and T cells, Invitrogen Gm8909 antibody (eBioscience, 34-1-2S) was used in flow cytometry on mouse samples . J Immunol (2009) ncbi
mouse monoclonal (28-14-8)
  • immunohistochemistry - paraffin section; brown rat
In order to test if renal stem cells exist in the adult kidney and participate in the acute injury repair, Invitrogen Gm8909 antibody (eBioscience, 12-5999-81) was used in immunohistochemistry - paraffin section on brown rat samples . J Am Soc Nephrol (2006) ncbi
Abcam
brown rat monoclonal (ER-HR 52)
  • immunohistochemistry - frozen section; mouse; 1:100; loading ...; fig 4c
Abcam Gm8909 antibody (Abcam, ER-HR 52) was used in immunohistochemistry - frozen section on mouse samples at 1:100 (fig 4c). Mol Neurodegener (2018) ncbi
brown rat monoclonal (ER-HR 52)
  • immunohistochemistry - frozen section; mouse; fig 5g
Abcam Gm8909 antibody (Abcam, ab15681) was used in immunohistochemistry - frozen section on mouse samples (fig 5g). Sci Rep (2016) ncbi
brown rat monoclonal (ER-HR 52)
  • immunocytochemistry; mouse; 1:200; loading ...; fig s8e
In order to find that coagulation factor XII modulates immune responses, Abcam Gm8909 antibody (Abcam, ER-HR52) was used in immunocytochemistry on mouse samples at 1:200 (fig s8e). Nat Commun (2016) ncbi
brown rat monoclonal (ERMP42)
  • immunohistochemistry - frozen section; brown rat; 1:100; fig 3
Abcam Gm8909 antibody (Abcam, ab15680) was used in immunohistochemistry - frozen section on brown rat samples at 1:100 (fig 3). Exp Ther Med (2016) ncbi
Articles Reviewed
  1. Dong M, Wang G, Chow R, Ye L, Zhu L, Dai X, et al. Systematic Immunotherapy Target Discovery Using Genome-Scale In Vivo CRISPR Screens in CD8 T Cells. Cell. 2019;178:1189-1204.e23 pubmed publisher
  2. Sivaram N, McLaughlin P, Han H, Petrenko O, Jiang Y, Ballou L, et al. Tumor-intrinsic PIK3CA represses tumor immunogenecity in a model of pancreatic cancer. J Clin Invest. 2019;130: pubmed publisher
  3. Bern M, Parikh B, Yang L, Beckman D, Poursine Laurent J, Yokoyama W. Inducible down-regulation of MHC class I results in natural killer cell tolerance. J Exp Med. 2019;216:99-116 pubmed publisher
  4. Magallanes Puebla A, Espinosa Cueto P, López Marín L, Mancilla R. Mycobacterial glycolipid Di-O-acyl trehalose promotes a tolerogenic profile in dendritic cells. PLoS ONE. 2018;13:e0207202 pubmed publisher
  5. Sato Y, Bolzenius J, Eteleeb A, Su X, Maher C, Sehn J, et al. CD4+ T cells induce rejection of urothelial tumors after immune checkpoint blockade. JCI Insight. 2018;3: pubmed publisher
  6. Gejman R, Chang A, Jones H, DiKun K, Hakimi A, Schietinger A, et al. Rejection of immunogenic tumor clones is limited by clonal fraction. elife. 2018;7: pubmed publisher
  7. James K, Cosway E, LUCAS B, White A, Parnell S, Carvalho Gaspar M, et al. Endothelial cells act as gatekeepers for LTβR-dependent thymocyte emigration. J Exp Med. 2018;215:2984-2993 pubmed publisher
  8. Theisen D, Davidson J, Briseño C, Gargaro M, Lauron E, Wang Q, et al. WDFY4 is required for cross-presentation in response to viral and tumor antigens. Science. 2018;362:694-699 pubmed publisher
  9. Umezu D, Okada N, Sakoda Y, Adachi K, Ojima T, Yamaue H, et al. Inhibitory functions of PD-L1 and PD-L2 in the regulation of anti-tumor immunity in murine tumor microenvironment. Cancer Immunol Immunother. 2019;68:201-211 pubmed publisher
  10. Vuckovic S, Minnie S, Smith D, Gartlan K, Watkins T, Markey K, et al. Bone marrow transplantation generates T cell-dependent control of myeloma in mice. J Clin Invest. 2019;129:106-121 pubmed publisher
  11. Walwyn Brown K, Guldevall K, Saeed M, Pende D, Önfelt B, MacDonald A, et al. Human NK Cells Lyse Th2-Polarizing Dendritic Cells via NKp30 and DNAM-1. J Immunol. 2018;201:2028-2041 pubmed publisher
  12. Nardo G, Trolese M, Verderio M, Mariani A, De Paola M, Riva N, et al. Counteracting roles of MHCI and CD8+ T cells in the peripheral and central nervous system of ALS SOD1G93A mice. Mol Neurodegener. 2018;13:42 pubmed publisher
  13. Wilson K, Liu H, Healey G, Vuong V, Ishido S, Herold M, et al. MARCH1-mediated ubiquitination of MHC II impacts the MHC I antigen presentation pathway. PLoS ONE. 2018;13:e0200540 pubmed publisher
  14. Luo N, Formisano L, Gonzalez Ericsson P, Sanchez V, Dean P, Opalenik S, et al. Melanoma response to anti-PD-L1 immunotherapy requires JAK1 signaling, but not JAK2. Oncoimmunology. 2018;7:e1438106 pubmed publisher
  15. Zacharakis N, Chinnasamy H, Black M, Xu H, Lu Y, Zheng Z, et al. Immune recognition of somatic mutations leading to complete durable regression in metastatic breast cancer. Nat Med. 2018;24:724-730 pubmed publisher
  16. Du X, Wen J, Wang Y, Karmaus P, Khatamian A, Tan H, et al. Hippo/Mst signalling couples metabolic state and immune function of CD8α+ dendritic cells. Nature. 2018;558:141-145 pubmed publisher
  17. Han Y, Liu Q, Hou J, Gu Y, Zhang Y, Chen Z, et al. Tumor-Induced Generation of Splenic Erythroblast-like Ter-Cells Promotes Tumor Progression. Cell. 2018;173:634-648.e12 pubmed publisher
  18. Mathew N, Baumgartner F, Braun L, O Sullivan D, Thomas S, Waterhouse M, et al. Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cells. Nat Med. 2018;24:282-291 pubmed publisher
  19. Alloatti A, Rookhuizen D, Joannas L, Carpier J, Iborra S, Magalhaes J, et al. Critical role for Sec22b-dependent antigen cross-presentation in antitumor immunity. J Exp Med. 2017;214:2231-2241 pubmed publisher
  20. Bruce D, Stefanski H, Vincent B, Dant T, Reisdorf S, Bommiasamy H, et al. Type 2 innate lymphoid cells treat and prevent acute gastrointestinal graft-versus-host disease. J Clin Invest. 2017;127:1813-1825 pubmed publisher
  21. Hauptmann M, Burkhardt N, Munderloh U, Kuehl S, Richardt U, Krasemann S, et al. GFPuv-Expressing Recombinant Rickettsia typhi: a Useful Tool for the Study of Pathogenesis and CD8+ T Cell Immunology in R. typhi Infection. Infect Immun. 2017;85: pubmed publisher
  22. Ansa Addo E, Zhang Y, Yang Y, Hussey G, Howley B, Salem M, et al. Membrane-organizing protein moesin controls Treg differentiation and antitumor immunity via TGF-β signaling. J Clin Invest. 2017;127:1321-1337 pubmed publisher
  23. Bracamonte Baran W, Florentin J, Zhou Y, Jankowska Gan E, Haynes W, Zhong W, et al. Modification of host dendritic cells by microchimerism-derived extracellular vesicles generates split tolerance. Proc Natl Acad Sci U S A. 2017;114:1099-1104 pubmed publisher
  24. Swanson P, Hart G, Russo M, Nayak D, Yazew T, Pena M, et al. CD8+ T Cells Induce Fatal Brainstem Pathology during Cerebral Malaria via Luminal Antigen-Specific Engagement of Brain Vasculature. PLoS Pathog. 2016;12:e1006022 pubmed publisher
  25. Tomic A, Varanasi P, Golemac M, Malic S, Riese P, Borst E, et al. Activation of Innate and Adaptive Immunity by a Recombinant Human Cytomegalovirus Strain Expressing an NKG2D Ligand. PLoS Pathog. 2016;12:e1006015 pubmed publisher
  26. Shifrin N, Kissiov D, Ardolino M, Joncker N, Raulet D. Differential Role of Hematopoietic and Nonhematopoietic Cell Types in the Regulation of NK Cell Tolerance and Responsiveness. J Immunol. 2016;197:4127-4136 pubmed publisher
  27. Collinson Pautz M, Slawin K, Levitt J, Spencer D. MyD88/CD40 Genetic Adjuvant Function in Cutaneous Atypical Antigen-Presenting Cells Contributes to DNA Vaccine Immunogenicity. PLoS ONE. 2016;11:e0164547 pubmed publisher
  28. Huang M, Zhang W, Guo J, Wei X, Phiwpan K, Zhang J, et al. Improved Transgenic Mouse Model for Studying HLA Class I Antigen Presentation. Sci Rep. 2016;6:33612 pubmed publisher
  29. Bernard Valnet R, Yshii L, Quériault C, Nguyen X, Arthaud S, Rodrigues M, et al. CD8 T cell-mediated killing of orexinergic neurons induces a narcolepsy-like phenotype in mice. Proc Natl Acad Sci U S A. 2016;113:10956-61 pubmed publisher
  30. Saranchova I, Han J, Huang H, Fenninger F, Choi K, Munro L, et al. Discovery of a Metastatic Immune Escape Mechanism Initiated by the Loss of Expression of the Tumour Biomarker Interleukin-33. Sci Rep. 2016;6:30555 pubmed publisher
  31. Papp S, Moderzynski K, Rauch J, Heine L, Kuehl S, Richardt U, et al. Liver Necrosis and Lethal Systemic Inflammation in a Murine Model of Rickettsia typhi Infection: Role of Neutrophils, Macrophages and NK Cells. PLoS Negl Trop Dis. 2016;10:e0004935 pubmed publisher
  32. Baptista M, Keszei M, Oliveira M, Sunahara K, Andersson J, Dahlberg C, et al. Deletion of Wiskott-Aldrich syndrome protein triggers Rac2 activity and increased cross-presentation by dendritic cells. Nat Commun. 2016;7:12175 pubmed publisher
  33. Wang Y, Hu C, Li J, You X, Gao F. Increased translocation of antigens to endosomes and TLR4 mediated endosomal recruitment of TAP contribute to nicotine augmented cross-presentation. Oncotarget. 2016;7:38451-38466 pubmed publisher
  34. Reinisch A, Thomas D, Corces M, Zhang X, Gratzinger D, Hong W, et al. A humanized bone marrow ossicle xenotransplantation model enables improved engraftment of healthy and leukemic human hematopoietic cells. Nat Med. 2016;22:812-21 pubmed publisher
  35. Göbel K, Pankratz S, Asaridou C, Herrmann A, Bittner S, Merker M, et al. Blood coagulation factor XII drives adaptive immunity during neuroinflammation via CD87-mediated modulation of dendritic cells. Nat Commun. 2016;7:11626 pubmed publisher
  36. Keilhoff G, Lucas B, Uhde K, Fansa H. Selected gene profiles of stressed NSC-34 cells and rat spinal cord following peripheral nerve reconstruction and minocycline treatment. Exp Ther Med. 2016;11:1685-1699 pubmed
  37. Ludigs K, Jandus C, Utzschneider D, Staehli F, Bessoles S, Dang A, et al. NLRC5 shields T lymphocytes from NK-cell-mediated elimination under inflammatory conditions. Nat Commun. 2016;7:10554 pubmed publisher
  38. Uruha A, Noguchi S, Hayashi Y, Tsuburaya R, Yonekawa T, Nonaka I, et al. Hepatitis C virus infection in inclusion body myositis: A case-control study. Neurology. 2016;86:211-7 pubmed publisher
  39. Pérez Girón J, Gómez Medina S, Lüdtke A, Munoz Fontela C. Intranasal Administration of Recombinant Influenza Vaccines in Chimeric Mouse Models to Study Mucosal Immunity. J Vis Exp. 2015;:e52803 pubmed publisher
  40. Sun H, Zhang J, Chen F, Chen X, Zhou Z, Wang H. Activation of RAW264.7 macrophages by the polysaccharide from the roots of Actinidia eriantha and its molecular mechanisms. Carbohydr Polym. 2015;121:388-402 pubmed publisher
  41. Wei H, Nash W, Makrigiannis A, Brown M. Impaired NK-cell education diminishes resistance to murine CMV infection. Eur J Immunol. 2014;44:3273-82 pubmed publisher
  42. Rauen J, Kreer C, Paillard A, van Duikeren S, Benckhuijsen W, Camps M, et al. Enhanced cross-presentation and improved CD8+ T cell responses after mannosylation of synthetic long peptides in mice. PLoS ONE. 2014;9:e103755 pubmed publisher
  43. Larsen J, Dall M, Antvorskov J, Weile C, Engkilde K, Josefsen K, et al. Dietary gluten increases natural killer cell cytotoxicity and cytokine secretion. Eur J Immunol. 2014;44:3056-67 pubmed publisher
  44. Lee Chang C, Bodogai M, Moritoh K, Olkhanud P, Chan A, Croft M, et al. Accumulation of 4-1BBL+ B cells in the elderly induces the generation of granzyme-B+ CD8+ T cells with potential antitumor activity. Blood. 2014;124:1450-9 pubmed publisher
  45. Furugaki K, Cui L, Kunisawa Y, Osada K, Shinkai K, Tanaka M, et al. Intraperitoneal administration of a tumor-associated antigen SART3, CD40L, and GM-CSF gene-loaded polyplex micelle elicits a vaccine effect in mouse tumor models. PLoS ONE. 2014;9:e101854 pubmed publisher
  46. Ramakrishnan R, Tyurin V, Tuyrin V, Veglia F, Condamine T, Amoscato A, et al. Oxidized lipids block antigen cross-presentation by dendritic cells in cancer. J Immunol. 2014;192:2920-31 pubmed publisher
  47. Mercadante A, Perobelli S, Alves A, Gonçalves Silva T, Mello W, Gomes Santos A, et al. Oral combined therapy with probiotics and alloantigen induces B cell-dependent long-lasting specific tolerance. J Immunol. 2014;192:1928-37 pubmed publisher
  48. Gujar S, Clements D, Dielschneider R, Helson E, Marcato P, Lee P. Gemcitabine enhances the efficacy of reovirus-based oncotherapy through anti-tumour immunological mechanisms. Br J Cancer. 2014;110:83-93 pubmed publisher
  49. Oliveira C, Querido B, Sluijter M, de Groot A, van der Zee R, Rabelink M, et al. New role of signal peptide peptidase to liberate C-terminal peptides for MHC class I presentation. J Immunol. 2013;191:4020-8 pubmed publisher
  50. Schneider C, Hudson A. The human herpesvirus-7 (HHV-7) U21 immunoevasin subverts NK-mediated cytoxicity through modulation of MICA and MICB. PLoS Pathog. 2011;7:e1002362 pubmed publisher
  51. Kiesel J, Buchwald Z, Aurora R. Cross-presentation by osteoclasts induces FoxP3 in CD8+ T cells. J Immunol. 2009;182:5477-87 pubmed publisher
  52. Gupta S, Verfaillie C, Chmielewski D, Kren S, Eidman K, Connaire J, et al. Isolation and characterization of kidney-derived stem cells. J Am Soc Nephrol. 2006;17:3028-40 pubmed